CVE-2023-7238Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in Orthanc Osimis DICOM Web Viewer
Updated under an hour ago ()
Does this affect you?
It affects Orthanc Osimis DICOM Web Viewer and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.31%, higher than 22% of scored CVEs.
Do this next
Free account, 1 product
A XSS payload can be uploaded as a DICOM study and when a user tries to view the infected study inside the Osimis WebViewer the XSS vulnerability gets triggered. If exploited, the attacker will be able to execute arbitrary JavaScript code inside the victim's browser.
- CVSS
- 7.1 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
- Weakness (CWE)
- CWE-79
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.31% (percentile 22)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Jun 17, 2025
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
Orthanc Osimis DICOM Web Viewer orthanc:osimis_dicom_web_viewer (from the name) | 1.4.2.0-9d9eff4 | CNA record |
orthanc-server osimis_web_viewer orthanc-server:osimis_web_viewer | 1.4.2.0-9d9eff4 | NVD |
References
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-24-023-01government-resource, third-party-advisory, us-government-resource
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.